Evidence map›Paper›PMID 37867649›Full record

ArticleACS omega2023

Synthesis, Antifungal Ergosterol Inhibition, Antibiofilm Activities, and Molecular Docking on β-Tubulin and Sterol 14-Alpha Demethylase along with DFT-Based Quantum Mechanical Calculation of Pyrazole Containing Fused Pyridine-Pyrimidine Derivatives.

Nisheeth C Desai, Ashvinkumar G Khasiya, Dharmpalsinh J Jadeja, Jahnvi D Monapara, Aratiba M Jethawa, Bharti P Dave, Sree Kanth Sivan, Vijjulatha Manga, Pravin C Mhaske, Doongar R Chaudhary

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Bioactive Constituents ofDrug design, development and therapy · 2026
    Review
  3. Review
  4. Article
  5. Green Chemistry andRecent advances in anti-infective drug discovery · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Nisheeth C DesaiDivision of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, Gujarat 364002, India.ORCID https://orcid.org/0000-0001-6864-8661
Ashvinkumar G KhasiyaDivision of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, Gujarat 364002, India.
Dharmpalsinh J JadejaDivision of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, Gujarat 364002, India.
Jahnvi D MonaparaDivision of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, Gujarat 364002, India.
Aratiba M JethawaDivision of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, Gujarat 364002, India.
Bharti P DaveSchool of Science, Indrashil University, Rajpur, Gujarat 382 740, India.
Sree Kanth SivanDepartment of Chemistry, University College for Women, Osmania University, Koti, 500095 Hyderabad, India.
Vijjulatha MangaDepartment of Chemistry, University College for Women, Osmania University, Koti, 500095 Hyderabad, India.
Pravin C MhaskePost-Graduate Department of Chemistry, S. P. Mandali's Sir Parashurambhau College, Tilak Road, Pune 411030, Maharashtra, India.ORCID https://orcid.org/0000-0001-5453-7370
Doongar R ChaudharyCSIR-Central Salt and Marine Chemicals Research Institute, Bhavnagar 364002, Gujarat, India.ORCID https://orcid.org/0000-0003-1155-0705
Bhavnagar University · INUniversity College for Women · INCentral Salt and Marine Chemicals Research Institute · INIndrashil University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant fungal infections have become much more common in recent years, especially in immune-compromised patients. Therefore, researchers and pharmaceutical professionals have focused on the development of novel antifungal agents that can tackle the problem of resistance. In continuation to this, a novel series of pyrazole-bearing pyrido[2,3-

Identifiers

PMID37867649
PMCPMC10586022
OpenAlexW4387409015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.